4-54727315-A-G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_000222.3(KIT):​c.1638A>G​(p.Lys546Lys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0271 in 1,613,900 control chromosomes in the GnomAD database, including 716 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.023 ( 54 hom., cov: 33)
Exomes 𝑓: 0.027 ( 662 hom. )

Consequence

KIT
NM_000222.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 1.77

Publications

40 publications found
Variant links:
Genes affected
KIT (HGNC:6342): (KIT proto-oncogene, receptor tyrosine kinase) This gene encodes a receptor tyrosine kinase. This gene was initially identified as a homolog of the feline sarcoma viral oncogene v-kit and is often referred to as proto-oncogene c-Kit. The canonical form of this glycosylated transmembrane protein has an N-terminal extracellular region with five immunoglobulin-like domains, a transmembrane region, and an intracellular tyrosine kinase domain at the C-terminus. Upon activation by its cytokine ligand, stem cell factor (SCF), this protein phosphorylates multiple intracellular proteins that play a role in in the proliferation, differentiation, migration and apoptosis of many cell types and thereby plays an important role in hematopoiesis, stem cell maintenance, gametogenesis, melanogenesis, and in mast cell development, migration and function. This protein can be a membrane-bound or soluble protein. Mutations in this gene are associated with gastrointestinal stromal tumors, mast cell disease, acute myelogenous leukemia, and piebaldism. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2020]
KIT Gene-Disease associations (from GenCC):
  • gastrointestinal stromal tumor
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet, ClinGen, Ambry Genetics
  • piebaldism
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
  • cutaneous mastocytosis
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • mastocytosis
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Genomics England PanelApp, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.59).
BP6
Variant 4-54727315-A-G is Benign according to our data. Variant chr4-54727315-A-G is described in ClinVar as Benign. ClinVar VariationId is 255569.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.77 with no splicing effect.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.0233 (3548/152338) while in subpopulation EAS AF = 0.0487 (253/5190). AF 95% confidence interval is 0.0438. There are 54 homozygotes in GnomAd4. There are 1723 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 3548 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000222.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KIT
NM_000222.3
MANE Select
c.1638A>Gp.Lys546Lys
synonymous
Exon 10 of 21NP_000213.1
KIT
NM_001385284.1
c.1641A>Gp.Lys547Lys
synonymous
Exon 10 of 21NP_001372213.1
KIT
NM_001385290.1
c.1641A>Gp.Lys547Lys
synonymous
Exon 10 of 21NP_001372219.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KIT
ENST00000288135.6
TSL:1 MANE Select
c.1638A>Gp.Lys546Lys
synonymous
Exon 10 of 21ENSP00000288135.6
KIT
ENST00000412167.7
TSL:1
c.1629A>Gp.Lys543Lys
synonymous
Exon 10 of 21ENSP00000390987.3
KIT
ENST00000687109.1
c.1641A>Gp.Lys547Lys
synonymous
Exon 10 of 21ENSP00000509371.1

Frequencies

GnomAD3 genomes
AF:
0.0233
AC:
3549
AN:
152220
Hom.:
54
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00523
Gnomad AMI
AF:
0.0625
Gnomad AMR
AF:
0.0182
Gnomad ASJ
AF:
0.0755
Gnomad EAS
AF:
0.0484
Gnomad SAS
AF:
0.0333
Gnomad FIN
AF:
0.0163
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.0307
Gnomad OTH
AF:
0.0272
GnomAD2 exomes
AF:
0.0275
AC:
6895
AN:
251176
AF XY:
0.0286
show subpopulations
Gnomad AFR exome
AF:
0.00547
Gnomad AMR exome
AF:
0.00900
Gnomad ASJ exome
AF:
0.0669
Gnomad EAS exome
AF:
0.0492
Gnomad FIN exome
AF:
0.0181
Gnomad NFE exome
AF:
0.0295
Gnomad OTH exome
AF:
0.0283
GnomAD4 exome
AF:
0.0275
AC:
40150
AN:
1461562
Hom.:
662
Cov.:
33
AF XY:
0.0282
AC XY:
20537
AN XY:
727090
show subpopulations
African (AFR)
AF:
0.00370
AC:
124
AN:
33470
American (AMR)
AF:
0.0102
AC:
457
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0681
AC:
1779
AN:
26130
East Asian (EAS)
AF:
0.0392
AC:
1556
AN:
39694
South Asian (SAS)
AF:
0.0332
AC:
2867
AN:
86244
European-Finnish (FIN)
AF:
0.0175
AC:
934
AN:
53416
Middle Eastern (MID)
AF:
0.0319
AC:
184
AN:
5768
European-Non Finnish (NFE)
AF:
0.0275
AC:
30549
AN:
1111732
Other (OTH)
AF:
0.0282
AC:
1700
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
2137
4273
6410
8546
10683
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1112
2224
3336
4448
5560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0233
AC:
3548
AN:
152338
Hom.:
54
Cov.:
33
AF XY:
0.0231
AC XY:
1723
AN XY:
74488
show subpopulations
African (AFR)
AF:
0.00519
AC:
216
AN:
41586
American (AMR)
AF:
0.0182
AC:
278
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.0755
AC:
262
AN:
3468
East Asian (EAS)
AF:
0.0487
AC:
253
AN:
5190
South Asian (SAS)
AF:
0.0330
AC:
159
AN:
4824
European-Finnish (FIN)
AF:
0.0163
AC:
173
AN:
10616
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.0307
AC:
2086
AN:
68030
Other (OTH)
AF:
0.0279
AC:
59
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
179
357
536
714
893
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0305
Hom.:
52
Bravo
AF:
0.0227
Asia WGS
AF:
0.0460
AC:
160
AN:
3478
EpiCase
AF:
0.0326
EpiControl
AF:
0.0281

ClinVar

ClinVar submissions as Germline

Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
Gastrointestinal stromal tumor (3)
-
-
3
not specified (3)
-
-
2
not provided (2)
-
-
1
Hereditary cancer-predisposing syndrome (1)
-
-
1
Mastocytosis (1)
-
-
1
Piebaldism (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.59
CADD
Benign
6.3
DANN
Benign
0.42
PhyloP100
1.8
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs55986963; hg19: chr4-55593481; COSMIC: COSV55391099; COSMIC: COSV55391099; API